The Food and Drug Administration has revealed that the maker of a brand of eye drops linked to an outbreak of fatal bacterial infections failed to follow multiple safety protocols.

The FDA visited a Global Pharma Healthcare facility in India for an inspection in mid-February and found dozens of issues ranging from dirty equipment and clothing to missing safeguards and procedures.

The inspection came two-and-a-half weeks after the company voluntarily recalled the EzriCare artificial tears product because of possible contamination.

When the recall was issued, there were already 55 reports of adverse events, including eye infections, permanent loss of vision, and at least one death from a bloodstream infection.

Share:
More In Business
UPS Mass Hiring Event Set for Nov. 3-4
UPS is gearing up for a mass hiring event that could help a critical labor shortage affecting the U.S. across all industries. Jon Bowers, human resources director with UPS, joined Cheddar News to discuss the company's job fair known as 'Brown Friday,' which is slated to take place Nov. 3 and Nov. 4, ahead of the holiday season.
Realtors Found Liable for $1.8 Billion for Inflating Commissions
A Missouri jury found the National Association of Realtors and other brokerages liable for nearly $1.8 billion in damages on Tuesday. The jury found the parties conspired to keep commissions for home sales artificially high and the lawsuit looked at sales that took place between April of 2015 through June of 2022.
Load More